EURECCA consensus conference highlights about rectal cancer clinical management: The radiation oncologist's expert review

Radiotherapy and Oncology

Volumn 110, Issue 1, 2014, Pages 195-198

  Valentini, Vincenzo ^a   Glimelius, Bengt ^b   Haustermans, Karin ^c   Marijnen, Corrie A M ^d   Rödel, Claus ^e   Gambacorta, Maria Antonietta ^a   Boelens, Petra G ^d   Aristei, Cynthia ^f   Van De Velde, Cornelis J H ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b UPPSALA UNIVERSITY   (Sweden)

^c Department of Radiation Oncology University Hospitals Leuven Campus Gasthuisberg ^*  (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Combined modality therapy; Radiotherapy; Rectal cancer

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROPYRIMIDINE; OXALIPLATIN;

ARTICLE; CANCER CONTROL; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COLORECTAL CANCER; CONSENSUS DEVELOPMENT; EUROPE; HISTOPATHOLOGY; HUMAN; MEDICAL DECISION MAKING; OVERALL SURVIVAL; PANEL STUDY; PATIENT CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION ONCOLOGIST; RECTUM CANCER; RECTUM SURGERY; TOTAL MESORECTAL EXCISION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; ONCOLOGY; PRACTICE GUIDELINE; PROCEDURES; RECTAL NEOPLASMS; STANDARDS;

CHEMORADIOTHERAPY; HUMANS; PRACTICE GUIDELINES AS TOPIC; RADIATION ONCOLOGY; RECTAL NEOPLASMS;

EID: 84896074845     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.024     Document Type: Article

References (49)

1. F. Cellini, and V. Valentini Current perspectives on preoperative integrated treatments for locally advanced rectal cancer: a review of agreement and controversies Oncology (Williston Park) 26 2012 730 735 741
2. V. Valentini, C. Aristei, and B. Glimelius et al. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
3. C.J. van de Velde, C. Aristei, and P.G. Boelens et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe Eur J Cancer 49 2013 2784 2790
4. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24 (Pubitemid 38952855)
5. A.B. Benson III, T. Bekaii-Saab, and E. Chan et al. Rectal cancer J Natl Compr Canc Netw 10 2012 1528 1564
6. H. Brenner, A.M. Bouvier, and R. Foschi et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study Int J Cancer 131 2012 1649 1658
7. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 336 1997 980 987
8. K.C. Peeters, C.A. Marijnen, and I.D. Nagtegaal et al the TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701 (Pubitemid 350035641)
9. R. Sauer, T. Liersch, and S. Merkel et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 2012 1926 1933
10. B.D. Minsky Progress in the treatment of locally advanced clinically resectable rectal cancer Clin Colorectal Cancer 10 2011 227 237
11. C. Radu, A. Berglund, L. Pahlman, and B. Glimelius Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study Radiother Oncol 87 2008 343 349
12. P. Hatfield, M. Hingorani, and G. Radhakrishna et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity Radiother Oncol 92 2009 210 214
13. D. Pettersson, T. Holm, H. Iversen, L. Blomqvist, B. Glimelius, and A. Martling Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer Br J Surg 99 2012 577 583
14. D. Sebag-Montefiore, R.J. Stephens, and R. Steele et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial Lancet 373 2009 811 820
15. G.W. van, C.A. Marijnen, and I.D. Nagtegaal et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial Lancet Oncol 12 2011 575 582
16. R. Sauer, H. Becker, and W. Hohenberger et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
17. K. Bujko, M.P. Nowacki, A. Nasierowska-Guttmejer, W. Michalski, M. Bebenek, and M. Kryj Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Br J Surg 93 2006 1215 1223 (Pubitemid 44547018)
18. S.Y. Ngan, B. Burmeister, and R.J. Fisher et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04 J Clin Oncol 30 2012 3827 3833
19. K. Bujko Short-course preoperative radiotherapy for low rectal cancer J Clin Oncol 31 2013 1799
20. B.D. Minsky Short-course radiation versus long-course chemoradiation for rectal cancer: making progress J Clin Oncol 30 2012 3777 3778
21. R. Siegel, S. Burock, and K.D. Wernecke et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society BMC Cancer 9 2009 50
22. S. Pucciarelli, P. Toppan, and M.L. Friso et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome Dis Colon Rectum 47 2004 1798 1807 (Pubitemid 40064422)
23. C. Capirci, V. Valentini, and L. Cionini et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys 72 2008 99 107
24. F.M. Vecchio, V. Valentini, and B.D. Minsky et al the relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760 (Pubitemid 40779765)
25. V. Valentini, R.G. van Stiphout, and G. Lammering et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials J Clin Oncol 29 2011 3163 3172
26. L. Zorcolo, A.S. Rosman, and A. Restivo et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis Ann Surg Oncol 19 2012 2822 2832
27. I.D. Nagtegaal, and P. Quirke What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 2008 303 312
28. P. Quirke, G.T. Williams, N. Ectors, A. Ensari, F. Piard, and I. Nagtegaal The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8 2007 651 657 (Pubitemid 46995637)
29. N. Smith, and G. Brown Preoperative staging of rectal cancer Acta Oncol 47 2008 20 31
30. Short-course Preoperative Radiotherapy With Consolidating Chemotherapy vs. Preoperative Chemoradiation in Patients With Unresectable Rectal Cancer: Phase III Study. ClinicalTrials.gov Identifier:NCT00833131. Available at http://clinicaltrials.gov/ct2/show/NCT00833131?term= polish+trial+rectal+cancer&rank=1.
31. D. Pettersson, B. Cedermark, and T. Holm et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer Br J Surg 97 2010 580 587
32. D. Pettersson, B. Glimelius, H. Iversen, H. Johansson, T. Holm, and A. Martling Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial Br J Surg 100 2013 969 975
33. J.F. Bosset, L. Collette, and G. Calais et al. Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123 (Pubitemid 44394918)
34. J.P. Gerard, T. Conroy, and F. Bonnetain et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625 (Pubitemid 46630960)
35. M. Braendengen, K.M. Tveit, K. Bruheim, M. Cvancarova, A. Berglund, and B. Glimelius Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study Int J Radiat Oncol Biol Phys 81 2011 1017 1024
36. M. Tiv, M. Puyraveau, and L. Mineur et al. Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial Cancer Radiother 14 2010 530 534
37. M. Braendengen, K.M. Tveit, and A. Berglund et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer J Clin Oncol 26 2008 3687 3694
38. C. Aschele, L. Cionini, and S. Lonardi et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 2011 2773 2780
39. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer J Clin Oncol 30 2012 4558 4565
40. C. Rodel, T. Liersch, and H. Becker et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 2012 679 687
41. Schmoll H-J, Haustermans K, Price TJ, Nordlinger B, Hofhneinz R, aisne J-F. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: first results of the PETACC-6 randomized phase III trial. Abstr 3531, 31 ed. 2013.
42. T.H. van Dijk, K. Tamas, and J.C. Beukema et al. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer Ann Oncol 24 2013 1762 1769
43. A. Dewdney, D. Cunningham, and J. Tabernero et al. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) J Clin Oncol 30 2012 1620 1627
44. K. Dellas, T. Hohler, and T. Reese et al. Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer Radiat Oncol 8 2013 90
45. A. Jakobsen, J. Ploen, T. Vuong, A. Appelt, J. Lindebjerg, and S.R. Rafaelsen Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses Int J Radiat Oncol Biol Phys 84 2012 949 954
46. R.J. Myerson, V. Valentini, and E.H. Birnbaum et al. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma Int J Radiat Oncol Biol Phys 50 2001 1299 1308 (Pubitemid 32727809)
47. INTEnsification Radiotherapy With Accelerated Fractionation or ChemoTherapy And Local Excision After 3D External Radio-chemotherapy. ClinicalTrials.gov Identifier: NCT01653301. Available at http://clinicaltrials. gov/ct2/show/NCT01653301?term=interact&rank=3.
48. F. Bonnetain, J.F. Bosset, and J.P. Gerard et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer 48 2012 1781 1790
49. B.D. Minsky, C. Rodel, and V. Valentini Short-course radiation versus long-course chemoradiation for rectal cancer J Natl Compr Canc Netw 10 2012 1223 1231